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Changes in glycoconjugate production have been reported for 
tumor cells. In this study, we investigated the glycoconjugate 
expression pattern in normal human melanocytes and in a panel 
of 6 human melanoma cell lines with different metastatic 
capacity after s.c. inoculation into nude mice. Giycoconjugates 
were labeled in vitro with [35S] sulphate and [3H] glucosamine, 
purified from cells and culture medium by column chromatogra­
phy and identified by treatment with specific glycosidases. 
Characterization of the purified glycoconjugate fractions as well 
as alcian-blue staining of xenograft lesions revealed that hyal­
uronic acid (HA) is the main glycoconjugate produced by all cell 
lines. Highly metastatic cell lines expressed higher levels of HA 
than melanocytes and than weakly metastatic or non-meta- 
static cell lines. In addition, a shift in dominance from chondroi- 
tin-sulphate proteoglycan to heparan-sulphate proteoglycan 
was observed with increasing metastatic capacity. We also 
studied the expression and binding activity of the HA receptor 
CD44. Immunoprécipitation experiments indicated high CD44 
synthesis only in highly metastatic cell lines, but FACS analysis 
demonstrated approximately the same surface expression in 
melanocytes as in all cell lines. Adhesion assays to immobilized 
HA showed that CD44 can be present in an inactive or an active 
conformation. Our data suggest that a combination of increased 
HA production and the expression of CD44 on the cell surface 
may be associated with high metastatic potential of human 
melanoma cell lines in nude mice.
© 1995 Wiley-Liss, Inc.
The composition of the cell surface and the micro­
environment play important roles in tumor progression, espe­
cially metastasis formation. To create an environment condu­
cive to tumor-cell invasion, a balance has to be reached 
between extracellular-matrix (ECM) degradation and produc­
tion of new ECM components. Local disintegration of the 
ECM network results in expansion and subsequent hydration 
of the basic substance. In this environment, glycosaminogly- 
cans bind water accumulating at the tumor invasion zone due 
to vascular perturbation (Gabbert, 1985). This process is often 
accompanied and enhanced by the deposition of excessive 
amounts of hyaluronate (Knudson et al, 1989; Konishi et al,
1990) and/or chondroitin sulphate (Iozzo, 1988; Moczar et al, 
1993; Cauxe ta l, 1992).
In tumors, changes in glycoconjugate expression are promi­
nent at the invasion zone; not only the production of excessive 
quantities of various types of normal giycoconjugates by tumor 
cells, but also the deposition of chemically altered giycoconju­
gates, resulting in a pathologic ECM (Pauli and Knudson,
1988). A number of studies have been performed on animal 
tumor cell lines with different metastatic capacity derived from 
the same parental line (Kimata et al, 1983; Turley and Tretiak, 
1985; Schwartz-Albiez et al, 1988; Pogany et al., 1989; Robert­
son et al., 1989). Strongly increased expression of HA was 
found in highly metastatic sub-lines as compared with the 
weakly metastatic variants (Kimata et al, 1983; Turley and 
Tretiak, 1985). An important and specific role in tumor-cell 
invasion was reported for heparan-sulphate proteoglycans 
(HSPGs) in highly metastatic animal carcinoma and mela­
noma cell lines (Turley and Tretiak, 1985; Pogany et al, 1989; 
Robertson et al, 1989) and for chondroitin-sulphate proteogly­
cans (CSPGs) in a highly metastatic lymphoma cell line
(Schwartz-Albiez et al, 1988), Few studies have been pub­
lished on glycoconjugate expression by human tumor cell lines 
with different metastatic capacity (Moczar et al, 1993; Caux et 
al, 1992; Timar et al, 1989). A human melanoma sub-line with 
8- to ten-fold capacity to form liver colonies after intrasplenic 
injection than its parental counterpart was found to have a 
dominance of HSPG over CSPG at the cell surface (Timar et 
al, 1992).
Several studies have shown that CD44 can function as a 
receptor for HA (Aruffo et al, 1990; Thomas et al, 1992). 
Moreover, CD44 and some isoforms of CD44 are associated 
with tumor-cell dissemination in some human malignancies 
(Birch et a l, 1991; Horst et a ls 1991; Wielenga et al, 1993) and 
in animal tumor model systems (Gunthert et al, 1991). Study 
of the involvement of CD44 in melanocytic tumor progression 
has indicated that i.v. inoculation of nude mice with human 
melanoma-cell variants expressing high levels of CD44 gives 
rise to more extensive lung colonization than inoculation with 
cell-line variants expressing low levels of CD44 (Birch et al,
1991). However, the same group was unable to confirm the 
association after testing a broad spectrum of different mela­
noma cell lines (East et al, 1993).
The purpose of our study was to investigate whether a 
correlation exists between the metastatic potential of a panel 
of human melanoma cell lines after s.c. inoculation into nude 
mice and their glycoconjugate expression pattern in vitro. Since 
we found that the level of HA was markedly increased in the 
frequently metastasizing cell lines, we also studied the expres­
sion and functional activity of the hyaluronate receptor CD44, 
on these cell lines and on cultured normal human melanocytes.
MATERIAL AND METHODS 
Cell lines and tissue-culture conditions
All cell lines were derived from human melanoma metasta- 
ses, and included IF6 , 530, M14, Mel57, BLM and MV3 
(Danen et al, 1993). All cell lines were cultured in Dulbecco’s 
modified Eagle’s medium containing penicillin G (50 U/ml) 
and streptomycin (50 p-g/ml), and supplemented with 2 mM 
glutamine and 10% heat-inactivated FCS. Cultures were 
maintained at 37°C in a humidified 5% CO2 atmosphere. 
Isolation and propagation of normal human foreskin melano­
cytes was performed as described (Smit et al, 1989) in Ham’s 
F10 supplemented with 2% Ultroser-G synthetic serum 
(GIBCO, Grand Island, NY), glutamate, penicillin, streptomy­
cin, 0.1 mM IBMX (Sigma, St. Louis, MO) and 16 nM phorbol 
12-myristate 13-acetate (PMA) (Sigma).
[35S] sulphate and [3H] glucosamine labeling of cells
For radioactive labeling of the giycoconjugates, cells were 
grown to about 80% confiuency in 150-cm2 tissue-culture flasks
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and incubated with 20 ml medium containing 20 fxCi [35S] 
sulphate/ml and 10 \xCi [3H] glucosaminc (Amersham, Houten, 
The Netherlands) for 24 hr at 37°C. At the end of the labeling, 
culture medium was removed, centrifuged to remove cell 
debris and further processed for glycoconjugate analysis. After 
washing 3 times with PBS, cells were harvested from the 
bottom of the tissue-culture flask by means of a rubber 
policeman and stored at -80°C until further analysis.
Isolation o f glycoconjugates from cells and culture medium
All extractions and subsequent fractionations were per­
formed in the presence of a mixture of protease inhibitors [1 
mM phenylmethylsulphonylfluoride (PMSF)/5 mM benzami- 
dine-HCl/10 mM n-ethylmaleimide/0.1 M 6-aminohexanoic 
acid/5 mM iodoacetamide/10 mM sodium EDTA].
Labeled human melanoma cells were extracted with 4 M 
guanidine-HCl/50 mM sodium acetate (pH 5.8) and stirred for 
16 hr at 4°C. The residue obtained after centrifugation 
(20,000# for 30 min at 4°C) was extracted for an additional 16 
hr. The combined supernatants were extensively dialyzed at 
4°C against 7 M urea/50 mM Tris-HCl (pH 6 .8 ).
Secreted glycoconjugates were isolated from the culture 
medium. The culture medium was evaporated to dryness and 
the residue dissolved in 4 ml 7 M urea/50 mM Tris-HCl (pH 
6 .8). Unincorporated label was removed by gel filtration on a 
Bio-Gel P2 column (72,0 X 1.6 cm). The peak eluting in the 
void volume of the column was used for further purification.
Purification of glycoconjugates by 
Q-Sepharose-HL chromatography
Urea extracts from the melanoma cells or culture medium 
were chromatographed after centrifugation (100,000g for 30 
min at 4°C) and filtration through a 0.2-fxm filter on a column 
(1.6 x 10.0 cm) of Q-Sepharose-HL. The following solvents 
were used for this FPLC column: A, 7 M urea/50 mM Tris-HCl 
(pH 6 .8); B, 7 M urea/1 M NaCl/50 mM Tris-HCl (pH 6 .8). 
After application of the sample, a linear gradient was used 
with a flow rate of 2 ml/min. The gradient started at 0% B for
10 min and rose to 100% B at 60 min. The solvent composition 
was held at 100% B for 10 min, followed by equilibration back 
to 0% B. Fractions of 1 ml were collected and glycoconjugates 
were monitored by determination of the radioactivity in the 
fractions. The glycoconjugate-containing fractions were pooled, 
dialyzed against distilled water and stored at —20°C.
Identification of glycoconjugates
Glycoconjugates were identified according to established 
orocedures (Van den Heuvel et al.} 1989). Enzymes used were: 
leparitinase (Seikagaku Kogyo, Tokyo, Japan), chondroitin- 
ase ABC and (Streptomyces) hyaluronidase (Sigma). The 
specificity of the glycosidases was first checked on gly- 
cosaminoglycan standards. Heparitinase digestion was per­
formed at 43°C for 18 hr in 0.1 M sodium acetate/10 mM 
calcium acetate (pH 7.0). The enzyme was used at a concentra­
tion of 1 U/ml. Chondroitinase ABC digestion was performed 
at 37°C for 18 hr in 0.1 M Tris-HCl (pH 8.0) at an enzyme
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concentration of 0.25 U/ml. Hyaluronidase digestion was 
performed at 37°C for 16 hr in 50 mM sodium phosphate (pH 
5.0); the enzyme was used at a concentration of 10 U/ml. 
Quantitative proportions of glycosaminoglycans were deter­
mined by analyzing the radioactivity after BioGel P100 chroma­
tography.
To test for the presence of glycoconjugates in xenograft 
lesions, formalin-fixed and paraffin-embedded sections from 
s.c. tumors and from lungs containing metastases were stained 
using the alcian-blue technique at pH 2.8. To determine the 
glycoconjugate profile present in alcian-blue-positive xeno­
graft lesion sections from s.c. tumors and from lungs contain­
ing metastases were pre-incubated for 1 hr (and overnight) 
with various glycosidases, as described above, before alcian- 
blue staining. Parallel sections were treated with HNO2 for 
specific chemical degradation of HS.
Analytical procedures
Protein content was determined using the Bio-Rad protein 
assay using BSA as a standard.
Antibodies
The following MAbs were used: WT31 anti-CD3 (Taxet al, 
1983) as a negative control; CD44 MAbs NKI-P2 (Pals et a l}
1989); KM201, R7166.7 and 5F12 (Miyake et al, 1990); A1G3 
(Liao et al, 1993); A3D8 (Haynes et al, 1983); and 4B4 
anti-pl-integrin (Telen eta l, 1983).
Immunoprecipita tion
Sub-confluent monolayer cell cultures (75 cm2) were labeled 
overnight at 37°C in methionine-free Eagle’s minimum essen­
tial medium supplemented with 0.3 mCi [35S] methionine and 
10% dialyzed FCS. Before harvesting, cells were washed twice 
with PBS. NP40-lysis buffer [0.5% NP40, '15 mM NaCi, 10 mM 
Tris (pH 7.5), 1.0 mM PMSF and 4 |-ig/ml aprotinin] was then 
added for 10 min at 4°C, resulting in lysis of the labeled cells. 
Cell debris were scraped out of the culture flask, repeatedly 
aspirated into syringes, and forced through needles with 
decreasing diameters. Absorption to Concanavalin A-Sepha- 
rose (Pharmacia, Uppsala, Sweden) was performed to isolate 
the glycoprotein fraction from the total cell lysate. Finally, 
immunoprécipitation was performed with NKI-P2 MAb, as 
described (Danen et al., 1993). Immunoprecipitates were 
analyzed on a 10% SDS-polyacrylamide gel; gels were dried 
and exposed to X-ray films (Eastman Kodak, Arnhem, The 
Netherlands) at ~70°C using intensifying screens. Equal num­
bers of counts of the glycoprotein fraction were used for 
immunoprécipitation.
FA CS analysis
After short trypsinization of sub-confluent monolayers, cells 
were incubated for 30 min at 4°C with purified MAbs diluted in 
PBS containing 0.5% BSA and 0.02% sodium azide. After 3 
washes with PBS/BSA/sodium azide, cells were incubated 
with FITC-conjugated F(ab' ) 2 fragments of rabbit anti-mouse
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F ig u r e  2  -  Alcian-blue staining of sections of s.c. lesions of non-metastatic IF6 (a, b) and highly metastatic MV3 (c, d) cells without (a, 
c) and after (b, d) treatment with chondroitinase ABC. Note alcian-blue positivity in the MV3 tumor (c) and its disappearance after 
chondroitinase ABC treatment (d). Similar results were found with chondroitinase AC and hyaluronidase. Alcian-blue positivity did not 
disappear after pre-treatment with heparitinase. No alcian-blue positivity was found in the IF6 tumor (a). Bar, 50 jxm. The results with 
BLM tumors were similar to those with MV3 tumors, while 530, M14 and Mel 57 tumors showed results similar to those with IF6 tumors.
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Ig antibodies (Dako, Glostrup, Denmark) and analyzed on an 
Epics Elite (Coulter, Mijdrecht, The Netherlands).
Adhesion assays
HA isolated from human umbilical cord was purchased from 
Sigma. Polystyrene microtiter plates (Greiner, Alphen a/d 
Rijn, The Netherlands) were pre-coated with 150 jxl protamine 
chloride (200 |xg/ml) (KABI, Stockholm, Sweden) for 2 hr at 
room temperature. After washing with PBS, 100 \i\ HA 
solution (200 jxg/ml carbonate buffer, pH 9.6) were added and 
incubated overnight at room temperature. The plates were 
then washed with PBS. To avoid non-specific binding, plates 
were subsequently coated for 2 hr at 37°C with 1 % (w/v) BSA 
in PBS and then again washed with PBS.
Labeling of cells and adhesion was performed as described 
(Danen et al, 1993). In adhesion inhibition assays, cells were 
incubated with the appropriate MAbs for 30 min at 4°C before 
seeding into the wells.
RESULTS
In order to study the expression of glycoconjugates in 
relation to metastatic potential, we used a set of human 
melanoma cell lines with differing metastatic behavior. This set 
included 4 non-metastatic or sporadically metastasizing (IF6 , 
530, M14, Mel57) and 2 frequently metastasizing (BLM, MV3) 
cell lines after s.c. inoculation into nude mice (Danen et ai, 
1993). Cultured normal human melanocytes were also in­
cluded.
Expression and identification of glycoconjugates in tumors
Macroscopic examination of s.c. tumors of the 6 melanoma 
cell lines demonstrated marked differences in the consistency 
of the tumors. While the xenografts of the non-metastatic or 
weakly metastatic cell lines demonstrated a solid aspect, the 
lesions of the frequently metastatic cell lines showed a mucin­
like aspect. Conventionally stained histological sections of the 
s.c. tumors exhibited exclusively compact areas of tumor cells 
in IF6 , 530, M14 and Mel57 xenograft lesions. In contrast, s.c. 
tumors and tumor lesions in the lungs of the highly metastatic 
cell lines BLM and MV3 exhibited, in addition to besides 
compact areas (Fig. la), parts showing dispersed tumor cells 
with large intercellular spaces (Fig. lb) containing a mucin-like 
substance. Alcian-blue staining of sections from lesions of all 6 
cell lines showed marked positivity in BLM and MV3 tumors, 
indicating large quantities of glycoconjugates (Fig. 1 c). Very 
weak positivity, or none, was found in tumors derived from the 
other melanoma cell lines (not shown). To determine whether 
the glycoconjugates in BLM and MV3 lesions were produced 
by the cells of the tumor or by its stromal cells, alcian-blue 
staining was performed on cells cultured on coverslips. About 
half of the tumor cells of both cell lines contained markedly 
positive intracellular vacuoles (Fig. Id). Separate sections 
were treated with various glycosidases (chondroitinase AC, 
chondroitinase ABC, hyaluronidase and heparitinase) to deter­
mine the composition of the glycoconjugates in BLM and MV3 
xenograft lesions (Fig. 2). Incubation with all enzymes except 
heparitinase resulted in the disappearance of all or nearly all 
alcian-blue staining. HN02 treatment, like heparitinase, had 
no effect. These results strongly suggest that the glycoconju-
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gates in the intercellular spaces of BLM and MV3 lesions
represent mainly HA.
Expression and identification of glycoconjugates in vitro
Metabolic labeling with [35S] sulphate and [3H] glucosamine 
was used to identify the glycoconjugates produced by normal 
human melanocytes and the different melanoma cell lines in 
vitro. Purification of the cellular extract on Q-Sepharose-HL 
resulted for all the cell lines in a 3H peak separated from a 35S 
peak (Fig. 3), and which eluted as a broad peak between 0 and 
0.40 M NaCl from the column and the 35S peak between 0.60 
and 0.80 M NaCl.
Chromatography of urea extracts from cellular fractions on 
Q-Sepharose-HL resulted in elution profiles comparable with 
those observed for the culture media (Fig. 3), demonstrating 
that glycoconjugates were secreted in the culture medium.
The composition of the 35S-labeled glycoconjugates, from 
the cellular fraction as well as from the culture medium, 
showed differences between the cell lines studied. A clear 
change from CS to HS dominancy was observed in the 35S peak 
with increasing metastatic capacity of the cell line. This 
suggests similar changes in the ratio CSPG/HSPG (Table I).
Since the 3H-peak contains other products originating from 
[3H] glucosamine, in addition to HA, this fraction was treated 
with hyaluronidase to determine the production of HA. As 
shown in Table I, the highly metastatic cell lines produce by far 
the most HA, which is in line with the findings in the xenograft 
lesions.
Expression o f CD44
Since the production of HA is clearly elevated in the 
frequently metastasizing cell lines, and since CD44 may 
function as a receptor for HA, we were interested in expres­
sion of this receptor. To determine the level of biosynthesis of 
CD44 we performed immunoprecipitation experiments with 
[35S] methionine-labeled melanocytes and melanoma cells, 
using MAb NKI-P2, which recognizes an epitope present on all 
CD44 isoforms. CD44 could be precipitated from all cell lines, 
including melanocytes, but synthesis was high in BLM and 
MV3, intermediate in melanocytes, Mel57 and IF6 , and very 
low in 530 and M14 (Fig. 4). In addition, we studied the 
expression of CD44 by FACS analysis using the same MAb. 
We found marked CD44 expression on the surface of BLM 
and MV3 and of the other melanoma cell lines and normal 
melanocytes (Fig. 5). These data indicate that, in addition to 
the increased synthesis and secretion of HA, synthesis of the 
CD44-HA receptor is markedly higher in the highly metastatic 
cell lines, whereas CD44 surface expression is high on all cell 
lines tested.
Adhesion to hyaluronic acid
To investigate whether the expression of CD44 was reflected 
by the capacity to adhere to HA, we performed adhesion 
assays to immobilized HA. Two melanoma cell lines, 530 and 
M14, did not adhere to HA, while the other cell lines, 
including melanocytes, adhered moderately (Mel57) or strongly 
(melanocytes, IF6 , BLM, MV3) (Fig. 6). Pre-treatment of all 
cell lines with hyaluronidase or chondroitinase did not alter 
their binding capacity (data not shown).
To demonstrate that binding to HA was CD44-mediated, 
adhesion inhibition assays were performed with a panel of 6 
different CD44 MAbs. As a negative control, 4B4, an adhesion- 
blocking p-l-integrin MAb (Danen et ai, 1993) was used. As 
Figure 6 shows, 2 CD44 MAbs gave partial (5F12) or almost- 
complete to complete (R7166.7) inhibition of adhesion. No 
inhibition of adhesion of melanocytes and all melanoma cell 
lines was found with CD44 MAb KM201 (data not shown) and 
with the pl-integrin MAb 4B4, although all cells markedly
TABLE! -  GLYCOSAMINOGLVCAN COMPOSITION OF THE 3H AND 35S 
PEAKS AFTER Q-SEPHAROSE-HL CHROMATOGRAPHY
Cell line
Cellular fraction Culture medium
pH] HA1 RatioCS/HS2 [3HJ HA
Ratio
CS/HS
Melanocytes 259 3.0 162 3.8
IF6 299 2.6 293 3.2
530 365 2.2 291 1.7
M14 301 1.8 438 2.0
Mel57 460 1.3 561 1.4
BLM 623 0.6 726 0.8
MV3 928 0.4 786 0,5
Values are given in dpm/|ULg cellular protein as means of 3 (IF6, 
BLM) or 2 (melanocytes, 530, M14, Mel 57, MV3) experiments. 
PH] HA content was determined by hyaluronidase digestion of the 
^H-peak.-2Ratio CS/HS was determined by digestion of the 
35S-peak with chondroitinase ABC and heparitinase. Values are 
given as means of 2 experiments.
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F i g u r e  4  -  Biosynthesis of CD44 in human melanocytes (MCT) 
and melanoma cell lines. Sub-confluent monolayers were labeled 
with [35S] methionine: after isolation of glycoproteins from cell 
lysates with Con-A-Sepharose, equal numbers of counts were used 
for immunoprecipitation with MAb NKI-P2,
express pi integrins on their surface (Danen et ai, 1993). From 
these results we conclude that, while all cells express CD44 on 
their surface, CD44-mediated adhesion to HA is highly vari­
able.
DISCUSSION
Glycoconjugates are involved in various normal cellular 
processes, such as cell growth migration and adhesion. 
They may also be involved in various steps of the metastatic 
cascade. Transformed cells and tumor cells frequently demon­
strate altered glycoconjugate patterns, decreased HS and 
increased HA and CS expression (lozzo, 1988). In addition, 
rodent and human tumor cell lines with different metastatic 
capacity express altered glycoconjugate patterns (Caux et a l, 
1992; Moczar et al, 1993), especially increased HS/CS 
ratios with increased metastatic potential (Timar et a i ,  1989, 
1992).
Since little is known about glycoconjugate expression by 
human melanoma cell lines in relation to spontaneous metasta-
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sis, we investigated the expression pattern of melanocytes and 
a panel of 6 human melanoma cell lines with different 
metastatic behavior after s.c. inoculation into nude mice 
(Danen et al, 1993), As in other studies using weakly and 
strongly metastatic mouse-lymphoma cell lines, Lewis lung- 
tumor cell lines, mouse-melanoma cell lines and various 
rodent cell lines (Turley and Tretiak, 1985; Schwartz-Albiez et 
al ,  1988; Pogany etal, 1989; Robertson etal, 1989), we found 
that the production of glycoconjugates is enhanced in the 
highly invasive and metastatic cell lines. Like Timar et al 
(1992), we observed a shift from CSPG to HSPG dominance 
with increasing metastatic capacity.
Although changes in glycoconjugate synthesis have been 
found in co-cultures of colon carcinoma and smooth-muscle 
cells (lozzo et al, 1989) and in fibroblasts cultured in the 
presence of tumor-conditioned-medium (Edward et a l} 1992), 
our findings and observations by other groups (Turley and 
Tretiak, 1985; Kimata et al, 1983) indicate that most glycocon­
jugates in xenografts are synthesized by melanoma cells, since 
only a few stromal cells are present in tumor lesions, and 
melanoma cells show marked production in vitro.
Our finding that the HA receptor, CD44, was expressed on 
melanocytes and on all melanoma cell lines tested confirms 
previous findings (Birch et al.,  1991; East et al, 1993). The level 
of cell-surface expression does not correlate with the meta­
static propensity of the cell line, since all our cell lines 
including melanocytes show high expression. A possible expla­
nation for the higher synthesis in the frequently metastasizing 
cell lines BLM and MV3 may be that CD44, possibly after 
binding of “endogenous” HA, is shed into the culture medium. 
This may induce continuous synthesis of CD44, but this is not 
proven. Furthermore, East et ai (1993) reported that CD44 
mRNA levels in their melanoma cell lines did not correlate 
with the levels of surface expression, suggesting that the 
control of surface expression is regulated post-transcription- 
ally. In line with them, we found that melanoma cells express 
the 90-kDa CD44 form.
Since CD44 is a cell-adhesion molecule which functions in 
matrix binding and in cell migration and invasion, we studied
the functional activity of the receptor by determining its 
involvement in adhesion of the cells to immobilized HA. In 
agreement with East et al. (1993), we did not find a correlation 
between CD44 cell-surface expression and the ability of the 
cells to adhere to HA. Pre-treatment of the non-adhering or 
weakly adhering cell lines with hyaluronidase or chondroitin- 
ase did not induce or enhance binding to HA, therefore 
absence of adhesion was not due to binding of “endogenous” 
HA to the receptor. From these results, it appears likely that 
CD44 is present in an inactive state on the non-adhering cell 
lines. Cells that express CD44 do not constitutively bind HA, 
but binding activity can be induced by antibodies recognizing 
specific epitopes (Lesley et al, 1993). As activating antibodies 
were not available to us, we could not prove this supposition. 
Interestingly, East et al (1993) reported a reproducible but 
not significant increase of the binding capacity of CD44- 
positive human melanoma cells to HA with 2 different CD44 
MAbs.
The binding of our melanoma cells to IiA is indeed 
CD44-mediated, as was proven by the partial or complete 
inhibition with anti-CD44 MAbs. Regarding the mechanism of 
inhibition of adhesion by the R7166.7 MAb, we know that this 
is not due to direct blocking of the HA binding site, since the 
MAb does not block binding of fluorescein-labeled soluble HA 
to the cell lines (data not shown). Our interpretation of these 
data is that binding to immobilized HA might be blocked by 
Mab R7166.7 by restricting CD44 mobility or distribution. 
Alternatively, steric hindrance may be involved.
Our results with the KM201 Ab conflict with the report that
this antibody should inhibit binding to HA (Thomas et al,
1992). However, we and others (Kincade; Neame and Isacke,
personal communication) were unable to demonstrate KM201 
binding to human CD44.
In conclusion, we found that (i) melanocytes and non­
metastatic or weakly metastatic human melanoma cells secrete 
lower levels of glycoconjugates than do highly metastatic cell 
lines; (ii) there is a shift from CSPG to HSPG dominance with
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increasing metastatic capacity; (iii) HA is the main glycoconju- 
gate produced by all melanoma cell lines; (iv) the synthesis of 
HA and its receptor, CD44, are markedly higher in the 
frequently metastasizing cell lines; and (v) CD44 is strongly 
expressed on all cell lines but seems to be present in an inactive 
conformation on some cell lines. Our results confirm 
the potential role of HA and its receptor in the metastatic 
process.
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